Shares of Amgen Inc. AMGN shed 2.39% to $306.86 Tuesday, on what proved to be an all-around favorable trading session for the ...
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have earned a consensus recommendation of “Hold” from the twenty-four ...
1d
Zacks.com on MSNAmgen (AMGN) Stock Drops Despite Market Gains: Important Facts to NoteAmgen (AMGN) ended the recent trading session at $314.38, demonstrating a -0.53% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 1.77%.
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...
AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...
Investing.com -- Fitch Ratings has revised its outlook for biopharmaceutical company Amgen Inc (NASDAQ: AMGN ). to positive ...
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.
Cathie Wood’s ARK Invest is taking advantage of the recent dip in Tesla (TSLA) stock by purchasing 9,351 shares through its ...
The Dow Jones Industrial Average (DJINDICES: ^DJI) has changed a lot in recent years. In 2020, Salesforce, Amgen, and ...
5d
MedPage Today on MSNWill Medicare Price Negotiations Really Cut Rheum Drug Costs?Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...
Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results